Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$104.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medicinova Inc Lowers Consolidated Mid-year Outlook for FY 2013


Wednesday, 8 May 2013 07:00pm EDT 

Medicinova Inc announced that it has lowered its consolidated mid-year outlook for revenue from USD 650,000 to USD 3,257, operating profit from a loss of USD 4,856,000 to a loss of USD 5,147,000, ordinary profit from a loss of USD 4,856,000 to a loss of USD 5,149,000 and net profit from a loss of USD 4,856,000 to a los of USD 5,149,000, but raised the outlook for earning per share from a loss of USD 0.27 to a loss of USD 0.26, for the fiscal year ending December 2013. 

Company Quote

396.0
-11.0 -2.70%
19 Dec 2014